Company Name
Jiangsu Baozong & Baoda Pharmachem Co., Ltd.
Year of Establishment
2006
Enterprise Size
less than 10 person
Company Introduction
EU-GMP, FDA&PMDA approved, with CEP APIs, intermediates and contract manufacturing API: Fenbendazole, Flubendazole, Oxfendazole, Cimetidine, Famotidine, Dextromethorphan HBr, Chlophedianol HCl,Apixaban, Linagliptin. http://www.baozong-baoda.com
Main Competitive Advantages
Brandname,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Contract Manufacturing,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service,
Website
http://www.baozong-baoda.com
Milestone
• 2009: GMP Certificate for Veterinaries by Ministry of Agriculture at BZBD
• 2010: Fenbendazole CEP issued by EDQM; EU-GMP certificate by Afssaps;
• 2012: PMDA audited for Cimetidine
• 2012: Oxfendazole CEP issued by EDQM
• 2013: GMP Certificate issued for Cimetidine by SFDA
• 2014: Passed USFDA site audit for GMP complience